CMS117v14 Vaxelis as a 3-dose series but mapped to 4-dose series

XMLWordPrintable

    • Type: EC eCQMs - Eligible Clinicians
    • Resolution: Unresolved
    • Priority: Moderate
    • Component/s: None
    • None
    • MultiCare Health System
    • CMS0117v14
    • CMS0117v13
    • CMS0117v12
    • Hide
      Can you please provide guidance on proper mapping of the Dtap-Ipv-Hib-Hepb vaccine for Vaxelis specifically? We see this maps to CVX 146 but that requires a 4-dose scheduled, but on the manufacturer website they specify that this is a 3-dose vaccine. This is causing our physicians/APP to fail the measure because they are administering 3-doses for Vaxelis.
      Show
      Can you please provide guidance on proper mapping of the Dtap-Ipv-Hib-Hepb vaccine for Vaxelis specifically? We see this maps to CVX 146 but that requires a 4-dose scheduled, but on the manufacturer website they specify that this is a 3-dose vaccine. This is causing our physicians/APP to fail the measure because they are administering 3-doses for Vaxelis.

      Can you please provide guidance on proper mapping of the Dtap-Ipv-Hib-Hepb vaccine for Vaxelis specifically? We see this maps to CVX 146 but that requires a 4-dose scheduled, but on the manufacturer website they specify that this is a 3-dose vaccine. This is causing our physicians/APP to fail the measure because they are administering 3-doses for Vaxelis. What is the guidance on mapping for this vaccine specifically? The CDC is showing this as a 4-dose series due to a booster.

        1. image-2025-12-02-11-57-47-608.png
          image-2025-12-02-11-57-47-608.png
          101 kB

            Assignee:
            AIR EC eCQM Team
            Reporter:
            Stefanie Cummings
            Votes:
            0 Vote for this issue
            Watchers:
            3 Start watching this issue

              Created:
              Updated: